Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: A case–control study

Kang Min Kim, Sehyang Kim, Hyun Hwang, Hey Yun Kim, Dohyun Kim, Jung Hyun Park, Hye Ran Choo, Jin Woo Kim

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is uncommon but can result in severe destruction of the jaw. This case–control study investigated the therapeutic effects of daily or weekly administration of teriparatide in the management of MRONJ using a cohort for osteonecrosis of the jaw. Methods: Patients who were diagnosed with MRONJ and consented to teriparatide administration were assigned either to a group of daily injection or of weekly injection and completed a 4-week course of injection preoperatively and at least an 8-week course postoperatively. The control group received either the intraoperative rhBMP treatment (CG_BMP) or no additional perioperative treatment (CG_noBMP). The state of MRONJ was evaluated 2 months (T1) and 6 months (T2) postoperatively for all participants. Results: Either group of daily injection (8.35 weeks ± 1.58; n = 17) or weekly injection (9.17 ± 3.79; n = 12) showed significantly faster healing than those of CG_BMP (14.40 ± 6.08; n = 25) or CG_noBMP (15.79 ± 9.79; n = 39). MRONJ was resolved completely in 24 out of 29 participants who completed the course of teriparatide injections, whereas 46.9% of CG showed delayed resolution. Multiple regression analysis indicated 7.50 times (95% CI, 1.77–31.82) more likelihood of complete resolution of MRONJ for participants with teriparatide injections. Conclusion: A course of daily or weekly administration of teriparatide injections may improve treatment outcomes for patients with MRONJ.

Original languageEnglish
JournalOral Diseases
DOIs
StateAccepted/In press - 2023

Bibliographical note

Publisher Copyright:
© 2023 Wiley Periodicals LLC.

Keywords

  • antiresorptive
  • medication-related of the jaw (MRONJ)
  • osteonecrosis
  • parathyroid hormone (PTH)
  • teriparatide

Fingerprint

Dive into the research topics of 'Effects of daily versus weekly teriparatide for medication-related osteonecrosis of the jaw: A case–control study'. Together they form a unique fingerprint.

Cite this